Tony Butler
Stock Analyst at Rodman & Renshaw
(0.75)
# 3,971
Out of 4,996 analysts
105
Total ratings
32.35%
Success rate
-13.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $13.74 | +81.95% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.46 | +347.15% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $2.10 | +757.14% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.09 | +617.70% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.35 | +2,185.71% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.51 | +3,042.80% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.15 | +6,702.72% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.00 | +900.00% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $61.67 | +21.62% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $68.89 | -49.19% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $0.77 | +7,712.50% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.40 | +828.57% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.40 | +576.13% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.25 | +1,100.00% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.67 | +3,636.36% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.14 | +600.93% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.95 | +11.73% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.08 | +451.95% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.95 | +4,102.53% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.13 | +1,352.78% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.29 | +10,380.35% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.61 | +891.74% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.09 | +8,701.96% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.26 | -61.98% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.16 | +374.68% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $0.95 | +952.63% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.74 | +301.07% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $16.31 | +574.43% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $5.70 | +16,742.11% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $13.74
Upside: +81.95%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.46
Upside: +347.15%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $2.10
Upside: +757.14%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.09
Upside: +617.70%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.35
Upside: +2,185.71%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.51
Upside: +3,042.80%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.15
Upside: +6,702.72%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.00
Upside: +900.00%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $61.67
Upside: +21.62%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $68.89
Upside: -49.19%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.77
Upside: +7,712.50%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.40
Upside: +828.57%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.40
Upside: +576.13%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.67
Upside: +3,636.36%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $2.14
Upside: +600.93%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $8.95
Upside: +11.73%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.08
Upside: +451.95%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.95
Upside: +4,102.53%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $4.13
Upside: +1,352.78%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.29
Upside: +10,380.35%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.61
Upside: +891.74%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.09
Upside: +8,701.96%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.26
Upside: -61.98%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.16
Upside: +374.68%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $0.95
Upside: +952.63%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $3.74
Upside: +301.07%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $16.31
Upside: +574.43%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $5.70
Upside: +16,742.11%